Possibilities and Benefits of International Collaboration for Innovative Companies

1
Possibilities and Benefits of International
Collaboration for Innovative Companies

• Martin Wassell
• Managing Director
• European Institutes

2
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

3
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

4
What is an Innovative Company?
Value Chain Innovation
3
Business Model Innovation
Process Innovation
2
4
Product Innovation
Structural Innovation
Application Innovation
Frontier Research
Main Street (Mature)
Revenue Growth
Early Market
Death Valley
Bowling Alley
Tornado
Main Street (Early)
Main Street (Declining)
Fault Line
End Of Life
1
Indefinitely Elastic Middle Period
Time
Young Innovative Company (YIC) less than 15
years old and spend at least 15 of expenditures
on RD
5
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

6
Why Collaborate .. Internationally?
Innovation Barriers
International Benefits?
International expertise for concept Development
and market compliance
International expertise for concept Development
and market compliance
Access the best suppliers, distributors and
customers?
International markets through large customers,
best suppliers and dist.
Access the best suppliers, distributors and
customers?
International markets through large customers,
best suppliers and dist.
Access the best suppliers, distributors and
customers?
Develop product, process and service solutions?
Best in class RD and technology development
Develop product, process and service solutions?
Best in class RD and technology development
Develop product, process and service solutions?
Scale up to access markets National and
International?
Customer, supplier and distribution Networks for
rapid market access
Scale up to access markets National and
International?
Customer, supplier and distribution Networks for
rapid market access
Scale up to access markets National and
International?
Maximise product lifespan and profit?
Extended product, process or service life market
acceptance and penetration
Maximise product lifespan and profit?
Extended product, process or service life market
acceptance and penetration
Maximise product lifespan and profit?
7
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

8
FP7 An Opportunity for Collaboration

• 1.4Bn
• Thematically unrestricted
• 100 cost reimbursed
• Excellent cash flow

9
Open Innovation and the Smart Use of Public
Funding
10
How This Programme Supports International
Collaboration
The DNA of Successful International Business
Development
11
How This Programme Supports International
Collaboration
The DNA of Successful International Business
Development
12
Developing The Value of New Ideas!
Customers
Competences
13
Developing The Value of New Ideas!
Performance
Flexibility
Functionality
EC funding is about creating sales, wealth
and high value jobs!
Customer Relationship
14
How This Programme Supports International
Collaboration
The DNA of Successful International Business
Development
15
The Value Proposition

• Develop the value differentiation of new
  offering ideas
• Provide access to experts to outsource/co-deliver
  the RD
• Develop your idea into a commercially validated
  prototype
• Build new technical capabilities into your value
  chain
• Develop new market access customer
  relationships
• Create 95 cost leverage for you with no dilution
  of IPR equity

16
Cost Leverage PotentialWhen You Carry Out Part
of the RD
Smart Use of Public funding
17
Total Project 3,500k costs 2,500k grant
71 reimbursed
RD Partner 1 University
RD Partner 6 SME
RD Partner 2 SME
You
500k costs 375k grant 75 reimbursed
RD Partner 3 SME
RD Partner 5 Research Inst
RD Partner 4 Large Firm
18
Total Project Effort Secured 3,500k
RD Partner 1 University
RD Partner 6 SME
RD Partner 2 SME
You
RD Partner 3 SME
RD Partner 5 Research Inst
RD Partner 4 Large Firm
155k of your costs, leverage 3,500k of RD
creating IPR for you at 95 leverage
19
Cost Leverage PotentialWhen You Outsource the RD
Smart Use of Public funding
20
Total Project 1,500k costs 1,125k grant
75 reimbursed
1,125k grant pays RD service
provider costs
Supply Partner 1 SME
RD Performer 1 Research Inst
Supply Partner 2 SME
Distributor Partner 6 SME
You
Supply Partner 3 SME
Distributor Partner 5 SME
RD Performer 1 Research Inst
Customer Partner 4 Large Firm
375kof SME costs Split 7 ways
53k each
21
Total Project Effort Secured 3,500k
RD Partner 1 University
RD Performer 1 Research Inst
RD Partner 6 SME
RD Partner 2 SME
You
RD Partner 3 SME
RD Partner 5 Research Inst
RD Performer 1 Research Inst
RD Partner 4 Large Firm
80k of your costs, leverage 1,500k of RD
creating IPR for you at 95 leverage
22
The Experts Available Through the Programme
23
No Cranks or Tyre Kickers!
24
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

25
Eurostars

• A Eurostars project European research and
  development project
• Address any technological area
• development of a new product, process or service
• Collaborative minimum of 2 participants from 2
  different Eurostars participating countries
• Main participant must be a research-performing
  SME from one of these countries
• Project should be market-driven with a maximum
  duration of 3 years
• Within 2 years of project completion
• product of the research should be ready for
  launch onto the market (except biomedical or
  medical projects, where clinical trials must be
  started within two years of project completion)
• First deadline 8th February 2008

26
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

27
Improved Functionality
Enables Pain Relief
Eluted drug
Polyvinyl Beads
Fibroid
Uterine artery
With this new alternative to invasive surgery,
we see our market growing to over 100m. A key
element of success was the access to RD skills
that we dont have internally. Andrew Lewis,
Technical Director, Biocompatibles Ltd
28
Improved Product Function
Improves Patient Outcome
The project allowed us to investigate novel
surface features to allow earlier product
fixation resulting in the potential for implant
longevity. Alan Taylor CEO, Finsbury Ltd
29
Decision Support Software Improves Flexibility
For Orthopaedic Implants

This technology represents a major part of our
product
development programme for the next 10 years Allen
Ritchie VP RD DePuy plc,
30
Agenda

• What is an Innovative Company?
• Why Collaborate . Internationally
• Barriers to Innovation
• Benefits of International Collaboration
• International Collaboration for Innovation
• Framework Programme 7
• Eurostars
• Case Studies
• Questions

31
Thank You